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Abstract
Background: Traditional Chinese medicine (TCM) herbal formulae provide valuable therapeutic strategies. However,
the active ingredients and mechanisms of action remain unclear for most of these formulae. Therefore, the
identification of complex mechanisms is a major challenge in TCM research.
Methods: This study used a network pharmacology approach to clarify the anti-inflammatory and cough
suppressing mechanisms of the Chinese medicinal preparation Eriobotrya japonica – Fritillaria usuriensis dropping
pills (ChuanbeiPipa dropping pills, CBPP). The chemical constituents of CBPP were identified by high-quality ultra-
performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF-MS), and anti-
inflammatory ingredients were selected and analyzed using the PharmMapper and Kyoto Encyclopedia of Genes
and Genomes (KEGG) bioinformatics websites to predict the target proteins and related pathways, respectively.
Then, an RNA-sequencing (RNA-Seq) analysis was carried out to investigate the different expression of genes in the
lung tissue of rats with chronic bronchitis.
Results: Six main constituents affected 19 predicted pathways, including ursolic acid and oleanolic acid from
Eriobotrya japonica (Thunb.) Lindl. (Eri), peiminine from Fritillaria usuriensisMaxim. (Fri), platycodigenin and
polygalacic acid from Platycodon grandiflorum (Jacq.) A. DC. (Pla) and guanosine from Pinellia ternata (Thunb.)
Makino. (Pin). Expression of 34 genes was significantly decreased after CBPP treatment, affecting four therapeutic
functions: immunoregulation, anti-inflammation, collagen formation and muscle contraction.
Conclusion: The active components acted on the mitogen activated protein kinase (MAPK) pathway, transforming
growth factor (TGF)-beta pathway, focal adhesion, tight junctions and the action cytoskeleton to exert anti-
inflammatory effects, resolve phlegm, and relieve cough. This novel approach of global chemomics-integrated
systems biology represents an effective and accurate strategy for the study of TCM with multiple components and
multiple target mechanisms.
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Background
A traditional Chinese medicine (TCM) preparation con-
tains various active ingredients that exhibit synergistic
effects on multiple targets to treat disease. However, the
potential mechanisms of action are difficult to research
systematically. Recently, network modeling and network
analysis technology have been proven useful for obtain-
ing gene and protein information and for identifying po-
tential targets and pathways [1]. The development of
analytical theory, such as systems biology and network
pharmacology, provides an opportunity to clarify the
complex and holistic mechanisms by which TCM treats
complex diseases [2].
Liang et al. obtained a better understanding of the net-
work pharmacology analysis of the herbal formula Liuwei
Dihuang [3]. The chemical constituents of Liuwei
Dihuang with high drug-likeness were selected, and the
related targets and pathway were predicted. Based on the
predicted drug-target-disease network, 6 compounds and
4 targets were verified. In another study, the pharmaco-
logical mechanism of Si-Wu-Tang was explored using
multi-level data integration [4]. The gene expression of
MCF-7 cells treated with Si-Wu-Tang was evaluated by
microarray, and the potential targets of each herb were
identified using the TCM Integrative Database. Using the
results, a herb-ingredient-target-drug was constructed for
gynecological disease treatment. Zhao et al. regulated the
Qingfei Xiaoyan Wan to alleviate asthma through a multi-
target network [1]. Differentially expressed genes and pro-
teins in lung tissue were detected and analyzed using the
gene ontology (GO) terms in the Kyoto Encyclopedia of
Genes and Genomes (KEGG). Li et al. studied Qishen
Yiqi to reveal its underlying multi-compound, multi-
target, multi-pathway mode of action [5]. The differen-
tially expressed genes were identified from a myocardial
infarction rat model treated with Qishen Yiqi, and their
functions were analyzed based on the cardiovascular
disease-related literature. Most of the above operations
of TCM network pharmacology were performed virtu-
ally, and neither trace ingredients nor drug absorption
were reflected at the biological level. The virtual evalu-
ation presented a huge and complex network in which
the main contact between compounds, targets and func-
tion was not clear, and it was not possible to conduct
further studies on key issues.
TCM has been used to treat chronic airway disease
for thousand years. Chronic bronchitis consists of air-
way inflammation, mucus secretion, and airway muscle
contraction. The inflammatory response was shown to
be dependent on a network of cytokines and chemo-
kines interactions, including tumor necrosis factor
(TNF)-α, interleukin (IL)-6, IL-8 and IL-1β [6]. Con-
sidering the complexity of this network, the main strat-
egy was multi-targeting treatment. Eriobotrya japonica
– Fritillaria usuriensis dropping pills (ChuanbeiPipa
dropping pills, CBPP), which have been used in the
clinical treatment of pulmonary diseases, is a modified
form of a famous ancient formula consisting of Eriobotrya
japonica (Thunb.) Lindl. (Eri), Fritillaria usuriensis
Maxim. (Fri), Platycodon grandiflorum (Jacq.) A. DC.
(Pla), Pinellia ternata (Thunb.) Makino. (Pin) and volatile
oil extracts from Mentha haplocalyx Briq. (Men). In
clinical practice, CBPP had good clinical therapeutic ef-
fects for eliminating cough, phlegm, chronic bronchitis
and inflammation of the lungs.
In this study, we developed an integrated network
pharmacological approach combining the virtual predic-
tion of targets and pathways with the experimentally de-
termined differences in gene expression to explain the
synergistic mechanism of CBPP. After high-quality ultra-
performance liquid chromatography (UPLC) separation,
ingredients of CBPP were analyzed using quadrupole
time-of-flight mass spectrometry (Q-TOF-MS) to obtain
structural information. Representative compounds were
selected and their targets and pathways were analyzed
using PharmMapper and KEGG, respectively. Concomi-
tantly, the expression of functional genes was determined
using RNA-Sequencing (RNA-Seq)-based transcriptome
analysis of the lung tissue from rats with chronic bron-
chitis. An integrated analysis was used to clarify the rela-
tionship between the major active components, the
affected targets and affected pathways.
Methods
Plant materials
CBPP (Lot No. 633003) and its extract were donated by
No.6 TCM Factory of Zhongxin Pharmaceuticals (Tianjin,
China). The quality of each herb and CBPP extract were
verified by marker compounds. Quantitative methods and
results are provided in the Additional file 1.
Chemicals and reagents
UPLC-grade acetonitrile and acetic acid were purchased
from Merck (Darmstadt, Germany). Deionized water was
purified using the Milli-Q system (Millipore, Bedford, MA,
USA). Lipopolysaccharides (LPS) were obtained from
Sigma Corporation (St. Louis, USA). Bacillus calmette-
guerin (BCG) injections were purchased from Siqi
Biological Pharmaceutical Corporation (Hunan China, Lot
No. 130631). Dexamethasone (Dex) tablets were purchased
from Xianju Pharmaceutical Corporation (Zhejiang China,
Lot No. 131223).
UPLC/Q-TOF-MS analysis
A UPLC System (Waters, USA) equipped with a photo-
diode array detector was used. An Acquity BEH C18
column (2.1 × 100 mm, 1.7 μm; Waters, USA) was used for
the separation. The injection volume was 5 μL at a
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concentration of 10 mg/mL CBPP extract. The mobile
phase consisted of 0.1 % (v/v) formic acid solution (A)
and acetonitrile (B) at a flow rate of 0.4 mL/min. A gra-
dient program was used as follows: 0 min, 2 % B;
13 min, 30 % B; 16 min, 50 % B; 25 min, 80 % B; 28 min,
100 % B; 28–30 min, 100 % B. The column temperature
was 30 °C.
Accurate mass measurements were collected using a
Q-TOF Premier with an electrospray ionization system
(Waters, USA). The electrospray capillary voltage was
3.0 kV and 2.5 kV for the positive and negative modes,
respectively. The sample cone voltage was 30 V. The
nebulization gas was 600 L/h at 350 °C. The cone gas
was 50 L/h, and the source temperature was 110 °C.
The Q-TOF Premier acquisition rate was 0.1 s, with a
0.02 s inter-scan delay. The instrument was operated
with the first resolving quadrupole in a wide pass mode
(50 – 2,500 Da).
Anti-inflammatory target prediction and docking
Candidate ingredients with anti-inflammatory activity or
the main components that have been reported for the
four herbs were selected, and their structures were put
into the PharmMapper database (http://59.78.96.61/
pharmmapper/) for target prediction. Pathway analysis
was carried out using the KEGG website (http://www.ge-
nome.jp/kegg/).
To further evaluate the selectivity, candidate molecules
were optimized using SYBYL X2.0 and then docked to
targets. The crystal structures of potential target proteins
were obtained from the Protein Data Bank (ID: 3EQF,
3V6R, 3KJF, 3LDX, 4KXZ, 4EFL and 3CU8). PDBQT-
format files of the targets and ligands were prepared
using AutoDockTools. 30 genetic algorithm (GA) runs
were used to simulate ligand-receptor binding. The step
size parameters of quaternion and torsion were set to 30.
For each compound, 30 independent runs were performed.
The default values were used for the other parameters.
Ethics statement
Animal treatment and maintenance were performed in
accordance with the Principle of Laboratory Animal
Care (NIH Publication no. 85–23, revised 1985), and the
Animal Ethics Committee of Nankai University ap-
proved the experimental protocol.
LPS-induced chronic bronchitis in rats
Sprague-Dawley (SD) rats weighing 140–160 g were pur-
chased from the Experimental Animal Center of the
National Institute for the Control of Pharmaceutical and
Biological Products (Beijing, China), and the batch number
was 0006407. All of the animals were housed at a
temperature of 21–23 °C, a relative humidity of 40–60 %,
and a photoperiod of 12 h light-12 h dark. The animals had
free access to food and water. They were allowed 3 days
to adjust to the facilities before experimentation.
Chronic bronchitis model was induced by BCG treat-
ment (2.5 mL/kg) through the caudal vein, and LPS
treatment (1 mg/kg) through endotracheal instillation
1 week later [7]. Then, the animals were randomly di-
vided into six groups (n = 10): the control group (Con),
the model group (Mod), the Dex group, and the high,
middle, and low CBPP dose groups (CBPP-H, CBPP-M,
CBPP-L). One week after LPS injection, drugs were given
to each group continuously for 2 weeks. The treatment
groups received CBPP at one of three doses (30, 60, or
120 mg/kg daily) or Dex (1.2 mg/kg daily). The Con and
Mod received normal saline.
Blood samples were drawn from the abdominal aorta
of anaesthetized rats. The serum supernatant was stored
at -20 °C for subsequent testing. Then, the animals were
euthanized. Bronchoalveolar lavage fluid (BALF) was
prepared by washing the left lung three times with
10 mL of phosphate-buffered saline (PBS). The BALF
was centrifuged at 1,500 rpm for 10 min, and the super-
natant was collected and stored at -20 °C for cytokine
analysis. The cell pellets were resuspended in PBS
(1 mL), and the leukocyte counts were determined using
a hemocytometer. Concentrations of TNF-α and IL-8 in
the serum and BALF were measured using ELISA kits
(Pierce/Endogen, Rockford). The left lung was rapidly
stored at -80 °C for future RNA-Seq analysis. The right
lung was fixed in 4 % paraformaldehyde for hematoxylin
and eosin (H&E) staining.
RNA-Seq analysis
Three lung samples, including Con, Mod and CBPP-M,
were selected for RNA-Seq-based transcriptome analysis
that was entrusted to Beijing Genomics Institute-Shenzhen.
The total RNA of lungs was sequenced via Illumina
HiSeqTM 2000 to obtain raw reads. Genes were screened
by comparison with the reference genome. The functional
annotation of differentially expressed genes was obtained
from a GO and pathway enrichment analysis.
The screened genes of the three samples were com-
pared to each other, including Con vs Mod, Con vs
CBPP-M and Mod vs CBPP-M. The Log2Ratio is the
division value of the differential expression quantity of
two groups. Cluster analysis was implemented with
MATLAB2011a (MathWorks, USA) using Euclidean dis-
tance and words connection. The protein interaction
with corresponding genes was analyzed using the String
9.1 website (http://string-db.org/).
Statistical analysis
The results were presented as the mean ± standard error
(SEM). A statistical evaluation of multiple comparisons
of the data was performed using one-way analysis of
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variance (ANOVA) followed by Bonferroni’s post hoc
test. For single comparison, the significance between
groups was determined using Student’s t test. The statis-
tical significance was set p < 0.05.
Results and discussion
Composition analysis and active ingredient identification
during CBPP extraction
The optimal UPLC/Q-TOF-MS method was used to
characterize CBPP extracts. The UPLC/diode array de-
tection analysis is shown in Fig. 1a. The total ion current
chromatograms in the positive and negative modes are
shown in Fig. 1b and c, respectively. The compositions
of all of the constituents were deduced based on their
molecular weight and reference, and 58 compounds
were identified in total (Additional file 2: Table S1).
Among the 58 compounds, 21 ingredients had anti-
inflammatory activity in previous reports, and detailed
information is presented in Fig. 2. The triterpene acid de-
rivatives were the main active ingredient in Eri, including
four of the ursane-type and two of the oleanane-type com-
pounds [8, 9]. There were five flavone derivatives and two
theaflavin derivatives in Eri [10, 11], and two peiminine
derivatives were identified in Fri [12, 13]. Oleanan esapo-
nin derivatives were derived from Pla, including three
platycodin and one polygalacin compounds [14, 15].
The active ingredients in Pin included guanosine and
coniferin [16, 17].
LPS-induced chronic bronchitis reduced by CBPP in rats
To evaluate the effects of CBPP treatment on LPS-
induced chronic bronchitis in rats, histological changes
and inflammatory cytokines were observed. As shown in
Fig. 3a, compared to the structural integrity of the lung
tissue in the Con group, LPS infection caused capillary
congestion, the obstruction of small airways by lympho-
cytic infiltrates, and a widening of the alveolar septa.
Treatment with CBPP significantly reduced the histolog-
ically detectable injury, reducing the obstruction of small
airways and the recruitment of inflammatory infiltrates.
The number of leukocytes in the BALF is an important
index for the evaluation of lung inflammation. Compared
to the Con group, the number of leukocytes was four
times greater in the Mod group. However, the decrease in
leukocytes in the groups treated with the CBPP varied in a
dose-dependent manner. These data indicated that CBPP
Fig. 1 UPLC/Q-TOF-MS analysis of CBPP extracts. a UPLC/UV chromatograms of the extracts; b, c TIC chromatograms in positive ESI mode and
negative ESI mode, respectively
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prevented the excessive infiltration of leukocytes into the
lung tissues. After LPS challenge, the concentrations of
typical cytokines, such as TNF-α and IL-8, were measured
in the serum and BALF (Fig. 3b). CBPP-L did not prevent
the release of IL-8 in the serum or of TNF-α in BALF;
however, treatment with higher doses of CBPP decreased
the production of these cytokines to varying degrees.
These results agreed with the histological changes that
were assessed above.
Target and pathway prediction of active ingredients
To further predict the targets and pathways, six represen-
tative ingredients were selected from the four herbs
(Fig. 4a). These ingredients were ursolic acid and olea-
nolic acid from Eri, peiminine from Fri, platycodigenin
and polygalacic acid from Pla, and guanosine from Pin.
All of the predicted targets and pathways are shown in
Additional file 1: Figure S7, and those screened from
bioinformatics analysis are shown in Fig. 4b. This
resulted in the identification of 15 pathways that were
related to immunity or inflammation, including focal
adhesion, mitogen activated protein kinase (MAPK),
peroxisome proliferators-activated receptors (PPAR),
toll-like receptors, transforming growth factor (TGF)-beta,
ErbB, GnRH, Wnt, natural killer (NK) cell-mediated cyto-
toxicity, vascular endothelial growth factor (VEGF), Fc
epsilon RI, antigen processing and presentation, B cell re-
ceptors, T cell receptors and complement and coagulation
cascades. Among these pathways, four were related to col-
lagen, including TGF-beta, focal adhesion, VEGF and
PPAR signaling pathways; five were related to smooth
muscle contraction, including adherens junction, gap
junction, tight junction, actin cytoskeleton and focal
adhesion.
RNA-Seq analysis of lung tissues
The effects of CBPP-M on LPS-induced chronic bronchitis
were further analyzed by RNA-Seq at the genetic level. The
Fig. 2 Chemical structures of the CBPP extract components with anti-inflammatory activity
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standards were set with a false discovery rate (FDR) ≤ 0.001
and |log2Ratio| ≥ 1. Differentially expressed genes were
screened under these standards in Con vs Mod, Con vs
CBPP-M and Mod vs CBPP-M. A total of 40 genes were
screened out and then clustered according to the log2Ratio.
The detailed data of the log2Ratio in the cluster are shown
in Additional file 3: Table S2. As shown in Fig. 4c, 34 genes
were up-regulated and six genes were down-regulated in
the Con vsMod. Most of differentially regulated genes were
up-regulated in the Mod. However, in the CBPP-M, these
were obviously down-regulated. Of the 34 up-regulated
genes, 28 were associated with collagen formation, muscle
contraction, inflammation or immunoregulation. Col1a1,
Col1a2, Col3a1, Loxl1 and Serpinf1 are associated with col-
lagen synthesis. Myh6, Myl7, Tnni, Scl4a1, Gbp4, Top2a
and Tpx2 are associated with muscle contraction. Ten
Fig. 3 CBPP alleviated LPS-induced chronic bronchitis in rats. a H&E staining images of rat lungs; b Leukocyte numbers in BALF and the ELISA of
the inflammatory cytokines TNF-α and IL-8 in BALF and serum. *p < 0.05 and **p < 0.01 compared to the Con. #p < 0.05 and ##p < 0.01, compared
to the Mod (n = 10)
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differentially expressed genes are associated with inflam-
mation: S100a8, S100a9, Ngp, Rsad2, Clqtnf6, Wif1, Sfrp2,
Grm3, Adamts17 and Serpinf1. Additionally, 12 genes are
associated with immunity: Fcnb, Clec4d, Cpa3, Rectnlg,
Igsf10, Scn3b, S100a8, S100a9, Ngp, Top2a, Tpx2 and
Opcml.
Proline-glycine-proline (PGP) are extracellular peptides
fragments found in collagen. Matrix metalloproteinase
(MMP)-9 is the main enzyme involved in this procedure.
The protein degradation products and enzymes were ele-
vated in the sputum. Aerosolized LPS administered to
mice has been shown to increase neutrophils and N-α-
PGP levels in the airway [18]. PGP are chemoattractants
in chronic neutrophilic inflammation associated with IL-8
and with recruiting inflammatory cells to the lung. In
addition, collagen could trigger the VEGF and TGF-
beta pathways. Gene expression profiling of the lung from
chronic obstructive pulmonary disease patients revealed
that Col6a3 and Serpinf1 were associated with emphy-
sema severity [19]. Col1a1, Col1a2 and Col3a1 are in-
volved in collagen I and III formation, and Loxl1 is usually
active in collagen substrates. Our data show that these
gene expression levels were noticeably decreased after
CBPP-M treatment. Therefore, intervention with CBPP
not only remitted airway inflammation but also reduced
sputum.
Myh6 and Myl7 are components of myosin chains. Tnni
confers calcium sensitivity to striated muscle actinomyosin.
With increasing Ca2+ concentration, the interaction of actin
and myosin increases and results in a cough. Chronic air-
way bacterial infections with symptoms of cough and
wheezing have been shown to be associated with neutro-
philic inflammation and high levels of IL-8 [20]. IL-8 could
increase the phosphorylation of the myosin light chain and
induce constriction in cystic fibrosis cells. In this paper,
leukocyte numbers and IL-8 levels in BALF were increased
in the Mod group. This result indicated that myosin-associ-
ated gene expression would be up-regulated. In muscle
cells, the cytoskeleton and its binding proteins provide the
power system for muscle contraction. Thus, the expression
of the aforementioned five genes decreased in CBPP-M
treatment indicates that CBPP could remit muscle contrac-
tion, arrest cough and relieve asthma.
In addition, S100a8 and S100a9 are calcium-binding
proteins that have anti-microbial activity. NF-kappa-B
could up-regulate the transcription of these genes. These
genes promote tubulin polymerization, phagocyte migra-
tion and the infiltration of granulocytes at sites of
wounding. Microtubule dynamics change with macro-
phage migration [21]. Ngp is a neutrophilic granule
protein that increases expression and is indicative of
inflammation. Wif1 and Sfrp2 are related to the
Wnt signaling pathway in the regulation of inflamma-
tion. Treatment with CBPP could down-regulate
the expression of these genes, demonstrating anti-
inflammatory and immune-regulatory function.
Network pharmacological action for CBPP
Airway inflammation is a complex network with many sig-
naling pathways. Modern research has demonstrated that
toll-like receptors, VEGF, MAPK, PPAR and the TGF-beta
signal pathway are activated in the development of airway
Fig. 4 Pathway prediction and RNA-Seq analysis of CBPP. a Structures of five representative active compounds that were identified by
UPLC/Q-TOF-MS; b Main targets and pathways as analyzed by PharmMapper and KEGG, respectively (network analysis); c RNA-Seq-based
transcriptome analysis by clustering and the functional classification of 34 up-regulated genes
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inflammation. In the central part of Fig. 5, the pro-
tein interaction of the above-mentioned 28 down-
regulated genes was further analyzed using String 9.1. Re-
markably, five protein interaction subgroups, including 15
genes, were described with ligatures. Functional proteins
were assigned to four different functional categories ac-
cording to collagen formation, muscle contraction, inflam-
mation and immunoregulation. Virtual docking validation
of predicted targets, which was performed using Auto-
Dock 4.0, further showed the binding energy and detailed
interaction information for the active ingredients and their
related protein targets.
Ursolic acid, oleanolic acid, platycodigenin and polyga-
lacic acid are typical pentacyclic triterpenoid compounds
from Eri and Pla. In this paper, these compounds were
found to reduce inflammation and bind to the MAP2K1
target (PDB: 3EQF) [22]. The binding energy was -8.84,
-8.92, -7.55 and -7.44 kcal/mol for the four compounds,
respectively. In addition, ursolic acid also binds to the
MAPK10 target (PDB: 3V6R; -9.46 kcal/mol), and olea-
nolic acid could bind to the CASP3 target (PDB: 3KJF;
-8.86 kcal/mol). According to the KEGG analysis, all of
the targets participate in the MAPK pathway. Surpris-
ingly, ursolic acid and oleanolic acid have been found
to down-regulate the phosphorylation of extracellular
signal-regulated kinase (ERK)1/2 and p38 and suppress
the MAPK signaling pathway [23]. In addition, the ex-
pression of MMP-9, a target gene of NF-kappa B, could
be eliminated by ursolic acid in TNF-alpha-induced rat
C6 glioma cell invasion [24]. Platycodin D inhibits cell
invasion by reducing MMP-9 enzyme activity and po-
tently suppressing the phosphorylation of ERK, p38,
and JNK [25]. Therefore, Eri and Pla could resolve
phlegm associated with inflammation by affecting the
MAPK pathway.
Peiminine from Fri has been generally thought to be a
cough suppressant in traditional Chinese herbal medi-
cine. As shown in Fig. 4, F2 (PDB: 3LDX) and TGF-
beta2 (PDB: 4KXZ) are its potential targets, with a bind-
ing energy of -10.96 and -8.81 kcal/mol, respectively.
These interactions affect the regulation of the actin cyto-
skeleton and the TGF-beta pathway. In COPD, inflamma-
tion was largely driven by IL-8, TNF-alpha and TGF-beta,
then cytokine and chemokine properties increased cough
and airway remodeling [26]. Our results were consistent
with the finding that peiminine can decrease the levels of
TGF-beta, ERK1/2, and NF-kappa B in lung tissues [27].
HRAS (PDB: 4EFL; -5.81 kcal/mol) and RAF1 (PDB:
3CU8; -7.36 kcal/mol) are regarded as latent targets for
guanosine. The two targets participate in focal adhesion
Fig. 5 Network pharmacology analysis through the protein interaction of differentially expressed genes and protein targets and signaling
pathway of representative ingredients of CBPP. The solid line represents an interaction directly confirmed through experiments or the literature,
and the dotted line represents interactions indirectly speculated through docking or the literature
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and the MAPK pathway. These two pathways are role in
reducing sputum and relieving inflammation (Fig. 4).
HRAS also affect tight junctions, which are related to
muscle contraction [28]. As a result, guanosine had anti-
inflammatory effects and reduced sputum levels through
MAPK and the focal adhesion-signaling pathway and
might relieve cough through HRAS targeting.
Conclusions
In this paper, a novel approach of global chemomics in-
tegrated systems biology was established to define the
multi-component and multi-target mechanism of action
of the CBPP dropping pill. Based on global chemomics
identified by UPLC/Q-TOF-MS, 6 typical components,
including ursolic acid, oleanolic acid, peiminine, platyco-
digenin, polygalacic acid, and guanosine from four
herbal medicines, were predicted to affect various targets
and pathways. To further validate these results, RNA-
Seq-based transcriptomics was applied to a rat model of
chronic bronchitis. The relevance between the thera-
peutic effect and effective compounds focused on immu-
noregulation, anti-inflammation, the inhibition of
collagen formation and the regulation of muscle con-
traction. As stated by the TCM theory, Pla (containing
platycodigenin and polygalacic acid) assists the monarch
drug Eri (containing ursolic acid and oleanolic acid) to
reduce inflammation and resolve phlegm by affecting
the MAPK pathway; Fri (containing peiminine) as minis-
ter drug relieved cough symptoms by actin cytoskeleton
and TGF-beta pathway; Pin (containing guanosine) an-
other minister drug reduced sputum and implemented
immunoregulatory actions through the MAPK and focal
adhesion pathways. A holistic regulatory network of
CBPP was generated for pulmonary disease treatment.
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